SCOPUS 정보 검색 플랫폼

Drug Discovery Today

Volumn 14, Issue 1-2, 2009, Pages 108-110

The use of combinatorial chemistry methodologies to discover novel chemotherapeutic agents

(1) Edwards, Paul J a

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANILIDE; AURORA KINASE INHIBITOR; CYCLIN D1; FENRETINIDE; NANOPARTICLE; RETINOIC ACID; TRANSCRIPTION FACTOR SNF;

BLOOD BRAIN BARRIER; CANCER INHIBITION; CHILDHOOD CANCER; COMBINATORIAL CHEMISTRY; DRUG BINDING SITE; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DESIGN; GENE; GENE MUTATION; HUMAN; INI1 GENE; NEUROBLASTOMA; PROTEIN MODIFICATION; RHABDOID TUMOR; SHORT SURVEY; STRUCTURE ACTIVITY RELATION; SURVIVAL RATE;

EID: 58149170444 PISSN: 13596446 EISSN: None Source Type: Journal
DOI: 10.1016/j.drudis.2008.11.008 Document Type: Short Survey

Times cited : (5)

References (10)

1
- 33646104935
- Molecular genetics of atypical teratoid/rhabdoid tumor
- Biegel J.A. Molecular genetics of atypical teratoid/rhabdoid tumor. Neurosurg. Focus 20 (2006) E11
- (2006) Neurosurg. Focus , vol.20
- Biegel, J.A.¹

2
- 0036141494
- The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors
- Biegel J.A., et al. The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors. Cancer Res. 62 (2002) 323-328
- (2002) Cancer Res. , vol.62 , pp. 323-328
- Biegel, J.A.¹

3
- 32244438873
- Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors
- Alarcon-Vargas D., et al. Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. Oncogene 25 (2006) 722-734
- (2006) Oncogene , vol.25 , pp. 722-734
- Alarcon-Vargas, D.¹

4
- 23944510163
- The role of gangliosides in fenretinide-induced apoptosis of neuroblastoma
- Lovat P., et al. The role of gangliosides in fenretinide-induced apoptosis of neuroblastoma. Cancer Lett. 228 (2005) 105-110
- (2005) Cancer Lett. , vol.228 , pp. 105-110
- Lovat, P.¹

5
- 44849137194
- Design and synthesis of 4-HPR derivatives for rhabdoid tumors
- Das B.C., et al. Design and synthesis of 4-HPR derivatives for rhabdoid tumors. Bioorg. Med. Chem. Lett. 18 (2009) 3805-3808
- (2009) Bioorg. Med. Chem. Lett. , vol.18 , pp. 3805-3808
- Das, B.C.¹

6
- 4344592378
- Fragment-based lead discovery
- Rees D.C., et al. Fragment-based lead discovery. Nat. Rev. Drug Discov. 3 (2004) 660-672
- (2004) Nat. Rev. Drug Discov. , vol.3 , pp. 660-672
- Rees, D.C.¹

7
- 0032820242
- Dynamic combinatorial chemistry and virtual combinatorial libraries
- Lehn J.-M. Dynamic combinatorial chemistry and virtual combinatorial libraries. Chem. A Eur. J. 5 (1999) 2455-2463
- (1999) Chem. A Eur. J. , vol.5 , pp. 2455-2463
- Lehn, J.-M.¹

8
- 2542542373
- Tethering: fragment-based drug discovery
- Erlanson D.A., et al. Tethering: fragment-based drug discovery. Annu. Rev. Biophys. Biomol. Struct. 33 (2004) 199-223
- (2004) Annu. Rev. Biophys. Biomol. Struct. , vol.33 , pp. 199-223
- Erlanson, D.A.¹

9
- 47149092363
- Discovery of an Aurora kinase inhibitor through site-specific dynamic combinatorial chemistry
- Cancilla M.T., et al. Discovery of an Aurora kinase inhibitor through site-specific dynamic combinatorial chemistry. Bioorg. Med. Chem. Lett. 18 (2008) 3978-3981
- (2008) Bioorg. Med. Chem. Lett. , vol.18 , pp. 3978-3981
- Cancilla, M.T.¹

10
- 10344236486
- Aurora-kinase inhibitors as anticancer agents
- Keen N., and Taylor S. Aurora-kinase inhibitors as anticancer agents. Nat. Rev. Cancer 4 (2004) 927-936
- (2004) Nat. Rev. Cancer , vol.4 , pp. 927-936
- Keen, N.¹ Taylor, S.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.